echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Jiangxi belt volume procurement open eight changes reveal what signal.

    Jiangxi belt volume procurement open eight changes reveal what signal.

    • Last Update: 2020-09-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical Network September 11 - In order to promote the procurement of drugs in Jiangxi Province, Jiangxi Province, the Office of the Joint Conference on centralized procurement of pharmaceutical medical supplies on September 8 issued the "Jiangxi Province drug belt procurement document."
    The "Documents" published this time, based on the general requirements, procurement scope, transaction rules, settlement payment rules, incentive and restraint mechanism of Jiangxi Province's drug belt procurement and use work plan, were issued by the Jiangxi Provincial Pharmaceutical Procurement Service Center in July this year. Jiangxi Province drug belt procurement documents (draft for comments) on the basis of the revision, and finally published the omeprazole and other 7 clinical use of large, high procurement amount of drugs to implement centralized band procurement, and published the agreed procurement volume, procurement cycle, declaration qualifications and other detailed details.
    01: Focus on these eight requirements to sort out the published Document, compared with the previous Draft for Comments, there have been some changes.
    first of all, the agreed purchase volume part.
    "Document" provides that: 1 enterprise selected, take the first year agreed procurement volume base of 50% for the first year agreed procurement volume, 2 home selection, take the first year agreed procurement volume of 75% for the first year agreed procurement volume, of which 50% as the lowest price of the selected enterprise's first year agreed procurement volume, 25% as the highest division of the enterprise's first year agreed procurement volume.
    , the change is mainly due to the special emphasis on the "first year", which also leaves room for subsequent collection changes.
    when national and local harvests are combined, how will they be implemented? In principle, when the national and local collection and collection of the same, should be based on the national collection policy, just published in Zhejiang Province drug belt procurement draft is in accordance with this provision, indicating that "if the national organization of drug belt procurement catalog is the same, will be adjusted in accordance with the requirements of national policy."
    But this Jiangxi "document" clearly, when the procurement cycle of the national drug centralized procurement results and Jiangxi Province drug centralized belt procurement results overlap, such as the selection of enterprises, the first year can be implemented in Jiangxi Province, the second year of renewal of the national election results;
    industry said this should be the result of a filing with the State Bureau.
    on the eligibility of quotations, the Document adjusts the order of assessment of economic and technical targets.
    "Document" proposed that, in accordance with the "notice on the development of Jiangxi Province drug centralized belt procurement enterprise registration", in the prescribed time according to the requirements of the enterprises to participate in the registration, can be on the registration of products to submit business quotation materials.
    not submit a business bid quotation, it shall be disposed of according to the abandoned bid.
    for enterprises with an economic and technical standard evaluation score of less than 70 points or who have not entered the business standard and comprehensive evaluation according to the economic and technical standard entry rules, the business bid quotation is invalid.
    the previous draft, in fact, the first requirement to assess the economic and technical standards, if the score of 70 points, directly lost the qualification for business bids.
    In terms of production capacity, the previous "request for comments" proposed capacity requirements for "enterprise tender varieties in 2019 production reached more than 2 times the number of this purchase (inclusive)," and the official version of the abolition of this mandatory requirement, then the enterprise commitment, which may also be related to some feedback from the previous industry, after all, in the absence of adequate assurance, enterprises generally will not blindly expand production capacity, which does not directly mean that enterprises do not have production capacity.
    another change in economic and technological standards is the change in the last update time for economic and technical targets.
    in the evaluation of economic and technical standards, the Document proposes that if there is an update of the relevant indicators of economic and technical standards of enterprises, the relevant supporting materials may be updated before the commercial tenders are opened.
    for non-compliing enterprises, Jiangxi also further treatment.
    For enterprises that have been included in the "violation list" of violations, in addition to canceling the enterprise's related declaration or eligibility for selection, depending on the serious circumstances, the enterprise or related products will be removed from the "violation list" within 2 years after participating in the centralized procurement activities of drugs in Jiangxi Province, will also report violations to the State Health Insurance Administration.
    note that the official document also adds penalties for cross-biding.
    "Document" clearly states that for those who collude with each other to declare and negotiate quotations, the enterprise shall be disqualed from participating in the centralized procurement of drugs in Jiangxi Province within two years from the date of inclusion in the "violation list".
    this was not addressed at all in previous drafts, and now it has to be reverie."
    The Document also adds detailed rules for drug quality testing and scoring, which provide for the alkalinity, clarity and color of the injection, relevant substances, moisture, load differences, visible foreign property, insoluble particles, content determination, etc.;
    of the same product rules clearly, the same product regulations 3 batches of samples of the minimum drug quality test score to calculate the economic and technical standard score.
    For Jiangxi in the volume procurement policy exploration, industry insiders pointed out that this time Jiangxi PPI-type drugs as the object of volume procurement, from the quality of drugs, production supply, price reduction and other aspects of the establishment of a review system, reflecting the local collection is in the process of accumulated experience.
    Jiangxi, through continuous adjustment and formulation of supporting policy measures, so that the results of the harvest in a certain period of time quickly appear, and for the rest of the country to provide case study.
    02 Trend: Special procurement of specific varieties with volume procurement has become a new feature of China's drug collection, in the gradual normalization of the same time, but also the formation of a nationwide flowering of the new situation.
    The implementation of centralized belt procurement in Jiangxi Province 7 varieties are related to digestive diseases, to this end, Jiangxi Province Health Insurance Bureau, the relevant person in charge has said that Jiangxi's future drug centralized belt procurement, will be in accordance with this line of thinking, focus on a single system, areas and diseases, in batches gradually advanced.
    Industry insiders pointed out that Jiangxi's centralized drug procurement does not set a threshold limit indicators, to maximize the opening of the market, the unestamented proton pump inhibitors into the procurement scope, promote open fair and just competition, minimize the phenomenon of similar drug substitution, can play a role in improving the effect of reducing prices and fees.
    At present, all provinces in the country have made corresponding attempts in the areas of unestailed variety belt procurement, according to disease category belt volume procurement, medical insurance payment standards, balance retention, etc., such as Qinghai over-evaluation of drugs and basic infusions with volume procurement; With volume procurement, Jiangxi to the unestailed and clinical use of large amounts of high procurement of drugs with volume procurement, Shanxi to the national and provincial organization of negotiations, centralized procurement of drugs, consumables in batches of drugs, consumables procurement, Wuhan to negotiate the procurement of insulin.
    this trend, the country and even around the belt procurement model may continue to increase.
    with the implementation of local mining policies, the industry environment will also force enterprises to reform the marketing model.
    under the influence of the New Deal, there will be a large number of small and medium-sized pharmaceutical companies in the future to face the risk of exit.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.